Cancer survival analysis in Hamburg 1995–2003: Assessing the data quality within a population-based registry

References

• Brenner H, Stegmaier C, Ziegler H. Long-term survival of cancer patients in Germany achieved by the beginning of the third millennium. Ann Oncol 2005; 16: 981–6
   PubMed Web of Science ®Google Scholar
• Association of Population-Based Cancer Registries in Germany in cooperation with the Robert Koch Institute. In: Cancer in Germany. 5th ed. Saarbrücken, Germany: 2006. Available from: http://www.ekr.med.uni-erlangen.de/GEKID/Doc/kid2006_englisch.pdf.
   Google Scholar
• Engel J, Eckel R, Aydemir U, Aydemir S, Kerr J, Schlesinger-Raab A, et al. Determinants and prognoses of locoregional and distant progression in breast cancer. Int J Radiat Oncol Biol Phys 2003; 55: 1186–95
   PubMed Web of Science ®Google Scholar
• Kerr J, Engel J, Eckel R, Hölzel D. Survival for rectal cancer patients and international comparisons. Ann Oncol 2005; 16: 664–72
   PubMed Web of Science ®Google Scholar
• Schlesinger-Raab A, Eckel R, Engel J, Sauer H, Löhrs U, Molls M, et al. Metastasiertes mammakarzinom: Keine lebensverlängerung seit 20 Jahren. Dt Ärztebl 2005; 102: A2706–A2714
   Google Scholar
• Fietkau R, Zettl H, Klocking S, Kundt G. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry. Strahlenther Onkol 2004; 180: 478–87
   PubMed Web of Science ®Google Scholar
• Tumorzentrum Land Brandenburg e.V. und Qualitätskonferenz Onkologie. Qualitätssicherung durch klinische Krebsregister: Sachbericht Onkologie 2004/2005. Frankfurt (Oder) 2006. Available from: http://www.tumorzentrum-brandenburg.de/pwp/(S(urgnipzt5jvjch55qslofra0))/uploads/Sachbericht_2004–2005.pdf.
   Google Scholar
• Sieveking GH. Das Krebsproblem in der öffentlichen Gesundheitsfürsorge. Zeitschrift für Gesundheitsverwaltung und Gesundheitsfürsorge. 1930; 1: 23–30
   Google Scholar
• Estève J, Kricker A, Ferlay J, Parkin DM, Facts and figures of cancer in the European Community. International Agency for Research on Cancer 1993. Available from: http://telescan.nki.nl/iarc.html.
   Google Scholar
• Cancer Registry of Norway, Institute of Population-based Cancer Research. Cancer in Norway 2004. Oslo. Available from: http://www.kreftregisteret.no/forekomst_og_overlevelse_2004/kreft_i_norge_2004web.pdf.
   Google Scholar
• Centre for Epidemiology, National Board of Health and Welfare. Cancer patient survival in Sweden 1980–2002. 2004. Published at and available from: www.sos.se/epc/publikationer/nyartikel/cancersurvival/cancerpatientsurvival.htm.
   Google Scholar
• Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research. Cancer in Finland 2002 and 2003. Helsinki 2005. Available from:, , http://www.cancerregistry.fi/eng/statistics/index_7.pdf.
   Google Scholar
• Integraal Kankercentrum Amsterdam. Overlevingscijfers IKA-regio (Noord-Holland and Flevoland) Last update 16-04-2007. Available from: http://www.ikcnet.nl/IKA/index.php?id=1735&nav_id=160&regio_id=117.
   Google Scholar
• National Statistics. Cancer Survival, England, 1999–2004. Last update 21-08-2007. Available from: http://www.statistics.gov.uk/downloads/theme_health/Survival_21_sites_1999_2003_by_age_group_v6.xls.
   Google Scholar
• Brenner H, Hakulinen T. Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration. Br J Cancer 2005; 92: 576–9
   PubMed Web of Science ®Google Scholar
• Colonna M, Grosclaude P, Faivre J, Revzani A, Arveux P, Chaplain G, et al. Cancer registry data based estimation of regional cancer incidence: Application to breast and colorectal cancer in French administrative regions. J Epidemiol Community Health 1999; 53: 558–64
   PubMed Web of Science ®Google Scholar
• Haberland J, Schön D, Bertz J, Görsch B. Vollzähligkeitsschätzungen von Krebsregisterdaten in Deutschland. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2003; 46: 770–4
   Google Scholar
• Percy C, van Holten V, Muir C, International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization; 1990.
   Google Scholar
• Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. Geneva: World Health Organization; 2000.
   Google Scholar
• Berkson J, Gage RP. Calculation of survival rates for cancer. Proceedings of Staff Meetings of the Mayo Clinic 1950; 25: 270–86
   PubMed Web of Science ®Google Scholar
• Cutler SJ, Ederer F. Maximum utilisation of the life table method in analyzing survival. J Chron Dis 1958; 8: 699–712
   PubMedGoogle Scholar
• Voutilainen ET, Dickman PW, Hakulinen T. SURV2: Relative survival analysis program. Software Manual Program version 2.02ß. Helsinki 1998, Manual updated August 9, 2000. Available from: http://www.cancerregistry.fi/surv2/manual.pdf.
   Google Scholar
• Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101–121
   PubMedGoogle Scholar
• Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933–42
   PubMed Web of Science ®Google Scholar
• Manton KG, Stallard E, Woodbury MA, Dowd JE. Time-varying covariates in models of human mortality and aging: Multidimensional generalizations of the Gompertz. J Gerontol A Biol Sci Med Sci 1994; 49: B169–B190
   Google Scholar
• Greenwood M. The errors of sampling of the survivorship tables. reports on public health and medical subjects. 1926; 33: 1–30
   Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 2307–16
   PubMed Web of Science ®Google Scholar
• Hakulinen T, Gibberd R, Abeywickrama K, Söderman B. A computer program package for cancer survival studies. Cancer Society of Finland Publication No. 39, Helsinki: Finnish Cancer Registry, 1988.
   Google Scholar
• Finnish Cancer Registry. SURV3: Windows software for relative survival analysis (version 3.01), last update December 20, 2002. Available from: http://www.cancerregistry.fi/surv3/.
   Google Scholar
• Teppo L, Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, et al. Cancer patient survival—patterns, comparisons, trends–a population-based Cancer Registry study in Finland. Acta Oncol 1999; 38: 283–94
   PubMed Web of Science ®Google Scholar
• Levi F, Randimbison L, Te VC, Franceschi S, La Vecchia C. Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993. Ann Oncol 2000; 11: 957–63
   PubMed Web of Science ®Google Scholar
• Capocaccia R, Gatta G, Roazzi P, Carrani E, Santaquilani M, De Angelis R, et al. The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 2003;14(Suppl 5):v14–v27.
   PubMed Web of Science ®Google Scholar
• Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in –1999: Results of the EUROCARE-4 study. Lancet Oncol ;8 1995; 2007: 773–83
   Google Scholar
• Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., Cancer incidence in five continents Vol. IX. IARC Scientific Publications No 160, Lyon, IARC.
   Google Scholar
• Blum K, Müller U. Dokumentationsaufwand im ärztlichen Dienst der Krankenhäuser Bestandsaufnahme und Verbesserungsvorschläge. Düsseldorf: Deutsche Krankenhaus Verlagsgesellschaft; 2003.
   Google Scholar
• Becker N, Brenner H, Klug SJ, Schilling FH, Spix C. Beiträge der Epidemiologie zur Krebsfrüherkennung DOI 10.1007/s00761-006-1127-2; Onkologe 2006 online.
   Google Scholar
• Neuhaus H. Vorsorge zur Prävention oder Früherkennung des Kolorektalen Karzinoms. Dt Ärztebl 1998; 95: A530–A537
   Google Scholar
• Altenhofen L, Knöpnadel J, Brenner G. Das Früherkennungsprogramm Kolonkarzinom-Screening in Deutschland—ein Zwischenbericht. Lecture at a symposium of the Epidemiological Cancer Registry Lower Saxony (Krebsregister Niedersachsen) 30th Oct 2004. Available from: http://www.krebsregister-niedersachsen.de/registerstelle/dateien/Vortrag3.pdf.
   Google Scholar
• Merzenich H, Giersiepen K, Kieschke J, Zeeb H. Früherkennung kolorektaler tumoren: Gibt es die optimale Screeningmaßnahme?. Gesundheitswesen 2005; 67: 803–8
   PubMed Web of Science ®Google Scholar
• Joensuu H, Toikkanen S. Cured of breast cancer?. J Clin Oncol 1995; 13: 62–9
   PubMed Web of Science ®Google Scholar
• Stenbeck M, Rosén M, Holm LE. Cancer survival in Sweden during three decade,1961–1991. Acta Oncol 1995; 34: 881–91
   PubMed Web of Science ®Google Scholar
• Gibis B, Busse R, Reese E, Richter K, Schwartz FW, Köbberling J. Mammography screening as a method for the early detection of breast cancer. Schriftenreihe HTA des DIMDI 3, 1st ed. Baden-Baden: Nomos Verlagsgesellschaft; 1998. Available from: http://gripsdb.dimdi.de/de/hta/hta_berichte/hta003_bericht_de.pdf.
   Google Scholar
• Nekolla EA, Griebel J, Brix G. Introduction of a mammography screening program in Germany—Benefit-risk considerations. Der Radiologe 2005; 45: 245–54
   PubMed Web of Science ®Google Scholar
• Kato I, Severson RK, Schwartz AG. Conditional median survival of patients with advanced carcinoma: Surveillance, epidemiology, and end results data. Cancer 2001; 92: 2211–9
   PubMed Web of Science ®Google Scholar
• Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prevent 2003; 12: 213–22
   PubMed Web of Science ®Google Scholar
• Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002; 90: 162–73
   PubMed Web of Science ®Google Scholar
• Siebert U, Mühlberger N, Behrend C, Wasem J. PSA- Screening beim prostatakarzinom. Systematischer gesundheitsökonomischer Review. Berichte aus der Schriftenreihe HTA des DIMDI Band 19, 2001, ISBN 3-7890-7165-X. Available from: http://gripsdb.dimdi.de/de/hta/hta_berichte/hta019_bericht_de.pdf.
   Google Scholar
• Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, et al. Cancer surveillance series: Interpreting trends in prostate cancer. Part I: Evidence of the effect of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999; 91: 1017
   PubMed Web of Science ®Google Scholar
• Merrill RM, Bird JS. Effect of young age on prostate cancer survival: A population-based assessment (United States). Cancer Causes Control 2002; 13: 435–43
   PubMed Web of Science ®Google Scholar
• Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000; 55: 876–80
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Long-term cancer patient survival achieved by the end of the 20th century: Most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer 2001; 85: 367–71
   PubMed Web of Science ®Google Scholar
• Bossard N, Velten M, Remontet L, Belot A, Maarouf N, Bouvier AM, et al. Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANGIM). Eur J Cancer 2007; 43: 149–60
   PubMed Web of Science ®Google Scholar